Waller C L, McKinney J D
Pharmacokinetics Branch, United States Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.
Chem Res Toxicol. 1995 Sep;8(6):847-58. doi: 10.1021/tx00048a005.
In the present study we have utilized comparative molecular field analysis (CoMFA), a three-dimensional quantitative structure-activity relationship paradigm, to explore the physico-chemical requirements for binding to the Ah (dioxin) receptor. Recent developments by Gillner et al. [(1993) Mol. Pharmacol. 44, 336-345] prompted us to review and revise our previous CoMFA/QSAR model [Waller, C. L., and McKinney, J. D. (1992) J. Med. Chem. 36, 3660-3666] to include a structurally-diverse training set of Ah receptor ligands ranging in size from naphthalene to indolo[3,2-b]carbazole nuclei. An exhaustive validation process utilizing external test sets and hierarchical cluster analysis routines was employed during model construction and is discussed herein. The limitations of the approach presented herein are discussed with respect to predictive ability of the CoMFA/QSAR models, which is demonstrated to be dependent on a balance between structural diversity and redundancy in the molecules comprising the training set. The results of our modified CoMFA/QSAR model are consistent with and unify all previously established structure-activity relationships established for less structurally-diverse training sets of Ah receptor ligands. As a result of the more complete nature of the series of molecules under examination in the present study, the CoMFA/QSAR steric and electrostatic field contour plots as well as the essential and excluded volume plots provide for a more detailed characterization of the molecular binding domain of the Ah receptor. The implications of the CoMFA/QSAR model presented herein are explored with respect to quantitative hazard identification of potential toxicants.
在本研究中,我们运用了比较分子场分析(CoMFA)这一三维定量构效关系范式,来探究与芳烃(二恶英)受体结合的物理化学要求。吉尔纳等人(1993年,《分子药理学》44卷,第336 - 345页)的最新研究促使我们回顾并修订之前的CoMFA/定量构效关系模型[沃勒,C.L.,和麦金尼,J.D.(1992年),《药物化学杂志》36卷,第3660 - 3666页],使其纳入一组结构各异的芳烃受体配体训练集,其大小范围从萘到吲哚并[3,2 - b]咔唑核。在模型构建过程中采用了利用外部测试集和层次聚类分析程序的详尽验证过程,本文对此进行了讨论。本文所提出方法的局限性在CoMFA/定量构效关系模型的预测能力方面进行了讨论,结果表明该预测能力取决于构成训练集的分子中结构多样性和冗余性之间的平衡。我们改进后的CoMFA/定量构效关系模型的结果与之前为结构较少样化的芳烃受体配体训练集建立的所有构效关系一致,并使其统一。由于本研究中所考察的分子系列具有更完整的性质,CoMFA/定量构效关系的空间和静电场等高线图以及必需和排除体积图为芳烃受体的分子结合域提供了更详细的表征。本文所提出的CoMFA/定量构效关系模型在潜在毒物的定量危害识别方面的意义也进行了探讨。